Skip to main content

Table 3 Viral load, RVR, ETR &SVR in Group 1 and Group 2 (Intention to Treat Analysis)

From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

 

Viral load detectable

Group 1(n = 18)

Group 2 (n = 18)

No

Yes

No

Yes

N (%)

N (%)

N (%)

N (%)

4th Week (RVR)

14 (77.7)

1 (6.6)

15 (83.3)

2 (11.1)

8th Week

15 (83.3)

(0)

17 (94.4)

0 (0)

12th Week (ETR)

15 (83.3)

(0)

17 (94.4)

0 (0)

24th Week (SVR)

15 (83.3)

(0)

14 (77.7)

3 (16.6)